Haemonetics HAE Blood Center — Costs incurred, net of reversals

Other segment segments

Similar metrics at other companies

GHC

GHCNet Periodic Defined Benefits Expense Reversal Of Expense Excluding Service Cost Component

-$31.07M+10.2%

ADMAPlasma Collection Centers — Nonoperating Income Expense

$68K—

IFFHealth & Biosciences — Additional charges, net

$2M-33.3%

OTT

OTTRNet Periodic Defined Benefits Expense Reversal Of Expense Excluding Service Cost Component

-$443K+65.4%

HUMCenterWell — Benefits, Losses and Expenses

$5.81B+23.6%

NNINelnet Bank — Intersegment expenses, net

$657K-7.5%

Questions, answered.

What is Haemonetics's blood center — costs incurred, net of reversals?

Haemonetics (HAE) reported blood center — costs incurred, net of reversals of -$22K in Q1 2026.

How has Haemonetics's blood center — costs incurred, net of reversals changed year-over-year?

Haemonetics's blood center — costs incurred, net of reversals decreased by 104.4% year-over-year, from $501K to -$22K.

What is the long-term trend for Haemonetics's blood center — costs incurred, net of reversals?

Over 4 years (2022 to 2026), Haemonetics's blood center — costs incurred, net of reversals has grown at a 136.0% compound annual growth rate (CAGR), from -$18K to -$558K.

What does blood center — costs incurred, net of reversals mean?

Represents the net impact of specific operational costs incurred by the Blood Center segment, adjusted for any reversals of previously recognized expenses. This metric helps investors understand the volatility and net expense burden associated with the segment's operational activities.